Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study

There was a substantial reduction in routine measurements of cardiometabolic risk factors following the COVID-19 pandemic, with variable recovery. The implications for missed diagnoses, worse prognosis, and health inequality are a concern.

Authors

Institutions

Publication Details

Journal
PLoS Medicine
Published
2024-11-26
DOI
https://doi.org/10.1371/journal.pmed.1004485
Citations
2
Primary Topic
COVID-19 and healthcare impacts
Type
article
Field-Weighted Citation Impact
0.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study

Julian Halcox, Kazem Rahimi, Jonathan Valabhji, Paul I. Welsh et al.
2 citations
PLoS Medicine
COVID-19 and healthcare impacts
0.57
article

Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study

Julian Halcox, Kazem Rahimi, Jonathan Valabhji, Paul I. Welsh, Benjamin Bray, Caroline Dale, Christopher Tomlinson, Christian Delles, Shinya Nakada, Reecha Sofat, Jill P. Pell, Daniel Mackay, Mehrdad A. Mizani, Mark J. Ashworth, Steffen Erhard Petersen, Naveed A. Sattar, Cathie Sudlow, Thomas Bolton, Frederick K. Ho, Ewan R. Pearson, Mamas Mamas
article en
2 citations

Abstract

There was a substantial reduction in routine measurements of cardiometabolic risk factors following the COVID-19 pandemic, with variable recovery. The implications for missed diagnoses, worse prognosis, and health inequality are a concern.

PLoS MedicineVol. 21(11)
University of Liverpool (GB), Queen Mary University of London (GB), University of Dundee (GB), King's College London (GB), British Heart Foundation (GB), Swansea University (GB), University of Oxford (GB), Health Data Research UK (GB), William Harvey Research Institute (GB), Genomics (United Kingdom) (GB), University College London (GB), Imperial College London (GB), Keele University (GB), University of Glasgow (GB)
Abbott Laboratories, Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Government of the United Kingdom, British Heart Foundation, Novo Nordisk, Medical Research Council
Good health and well-being
Openalex Percentile: Top 26%
COVID-19 and healthcare impacts
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.